NOROO Holdings has been selected to spearhead a major South Korean government-backed initiative aimed at accelerating the commercialization of bio-based 3-hydroxypropionic acid (3-HP).

 

3-HP is a high-value platform chemical seen as a key building block for next-generation sustainable materials.

 

The project, titled “Development of Feedstock Production and Value-Added Product Technologies to Promote the Bio-Based Polymer Market,” is supported by the Korea Evaluation Institute of Industrial Technology (KEIT) under the Ministry of Trade, Industry and Energy (MOTIE). 

 

It positions NOROO at the center of a national effort to shift industrial chemistry away from petroleum dependence and toward carbon-neutral bio-manufacturing.

 

NOROO will lead the “Large-Scale Demonstration of 3-HP Production from Waste Biomass,” overseeing the full value chain—from sourcing renewable feedstock and optimizing production processes to pilot-scale manufacturing and commercialization planning. 

 

The initiative will focus on turning agricultural and industrial waste into scalable inputs for industrial biotechnology.

 

A key pillar of the program is the development of bio-based acrylic acid–derived polymer materials, alongside the scale-up of 3-HP production and the demonstration of bio-acrylic acid synthesis via catalytic conversion processes. 

 

The work is expected to lay the groundwork for replacing conventional petrochemical-based acrylic acid with sustainable alternatives.

 

The effort brings together a broad Industry–Academia–Research consortium designed to integrate fundamental research, engineering, and industrial deployment into a single pipeline, accelerating the path from laboratory innovation to commercial application.

 

NOROO’s coatings subsidiary, NOROO Paint Co, will play a central role in applying the technology to real-world products. The company will focus on converting 3-HP into industrial raw materials for coatings, with an eye toward automotive, industrial, and architectural applications.

 

“This national project represents a pivotal inflection point for our industrial biotechnology division,” said a spokesperson for NOROO Holdings. “It marks our transition from a long-term 'Research (R)' phase to full-scale 'Development (D)' and commercialization phase, supported by significant investments in pilot plant infrastructure.”

 

The company further emphasized its alignment with national industrial strategy, stating, “The Ministry of Trade, Industry and Energy's proactive backing of these development-oriented projects clearly reflects a strong national commitment to expanding the industrial bio-material infrastructure. 

 

"NOROO Holdings is proud to lead this green transition, proving both the environmental sustainability and economic viability of next-generation chemical alternatives.”

 

NOROO says its Bio Fusion Research Institute has spent more than a decade developing microbial strain engineering and biosynthesis technologies for 3-HP. 

 

The group reports a 5-ton-scale production facility, validated stable output, EU REACH registration for derivatives, and a 99% biodegradation rate within 28 days—milestones it says support rapid scale-up and global commercialization.

 

With government backing and industrial partnerships in place, NOROO is positioning itself as a key player in the global shift toward bio-based chemicals and sustainable manufacturing systems.